American Biomedical Engineer
Jennifer Kehlet Barton is an American biomedical engineer who is Director of the BIO5 Institute at the University of Arizona. Barton develops optical techniques for the detection and treatment of cancer.
Early life and education
Barton earned her bachelor's degree in electrical engineering at the University of Texas at Austin.[1] She moved to the University of California, Irvine for her graduate studies. She then joined McDonnell Douglas, an aerospace engineering organisation that later became Boeing. She eventually returned to academia, moving to the University of Texas at Austin to research biomedical engineering for a doctoral degree.[1]
Research and career
In 1998, Barton joined the faculty of the University of Arizona.[2] She has investigated a variety of imaging techniques for diagnosing and treating cancer, including optical coherence tomography and fluorescence spectroscopy.[3] Barton has developed miniature, integrated endoscopes that combine both imaging modalities, with a particular focus on identifying the biomarkers that underpin ovarian cancer.[1][4][5] At the time, screening for ovarian cancer included pelvic ultrasounds and blood tests for CA-125, but neither of these techniques improve the outcomes for people with ovarian cancer.[6]
In 2018, Barton was named the Director of the University of Arizona BIO5 Institute.[2] The institute welcomes scientists from a variety of disciplines, including agriculture and pharmacy.[2]
In 2021, Barton joined the presidential chain of SPIE, a professional society for optical engineers. She served as president-elect in 2023, and assumed the role of president in 2024. [7]
